Altimmune Says Lead Drug Shows Significant Alcohol Reduction in Mid-Stage Study

기사 요약

Altimmune reports positive Phase 2 RECLAIM trial data for pemvidutide in AUD and plans to request an EOP2 meeting with the FDA.